Covington Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.2M Sell
18,653
-720
-4% -$730K 2.52% 9
2025
Q4
$20.8M Sell
19,373
-2,624
-12% -$2.51M 2.85% 9
2025
Q3
$16.8M Buy
21,997
+382
+2% +$284K 2.2% 13
2025
Q2
$16.8M Buy
21,615
+330
+2% +$256K 2.41% 11
2025
Q1
$17.6M Buy
21,285
+640
+3% +$533K 2.73% 9
2024
Q4
$15.9M Buy
20,645
+16
+0.1% +$13.2K 2.39% 12
2024
Q3
$18.3M Buy
20,629
+110
+0.5% +$98.9K 2.75% 8
2024
Q2
$18.6M Sell
20,519
-451
-2% -$361K 2.98% 7
2024
Q1
$16.3M Sell
20,970
-975
-4% -$694K 2.66% 10
2023
Q4
$12.8M Buy
21,945
+78
+0.4% +$45.5K 2.32% 13
2023
Q3
$11.7M Buy
21,867
+325
+2% +$167K 2.41% 12
2023
Q2
$10.1M Sell
21,542
-105
-0.5% -$44K 2.02% 16
2023
Q1
$7.43M Sell
21,647
-4,950
-19% -$1.67M 1.63% 22
2022
Q4
$9.73M Buy
26,597
+670
+3% +$238K 2.33% 13
2022
Q3
$8.38M Buy
25,927
+451
+2% +$143K 2.17% 15
2022
Q2
$8.26M Sell
25,476
-250
-1% -$75K 2.09% 14
2022
Q1
$7.37M Sell
25,726
-2,260
-8% -$582K 1.54% 22
2021
Q4
$7.73M Hold
27,986
1.57% 20
2021
Q3
$6.47M Sell
27,986
-260
-0.9% -$64.2K 1.39% 25
2021
Q2
$6.48M Buy
28,246
+189
+0.7% +$38K 1.42% 24
2021
Q1
$5.24M Buy
28,057
+79
+0.3% +$15.5K 1.27% 33
2020
Q4
$4.72M Buy
27,978
+21
+0.1% +$3.13K 1.22% 35
2020
Q3
$4.14M Buy
27,957
+150
+0.5% +$23.2K 1.19% 34
2020
Q2
$4.57M Sell
27,807
-50
-0.2% -$7.67K 1.4% 28
2020
Q1
$3.86M Sell
27,857
-40
-0.1% -$5.5K 1.47% 27
2019
Q4
$3.67M Hold
27,897
1.13% 40
2019
Q3
$3.12M Sell
27,897
-25
-0.1% -$2.78K 1.06% 46
2019
Q2
$3.09M Buy
27,922
+635
+2% +$74.8K 1.01% 50
2019
Q1
$3.54M Buy
27,287
+700
+3% +$85.1K 1.2% 38
2018
Q4
$3.08M Sell
26,587
-683
-3% -$76.3K 1.17% 41
2018
Q3
$2.93M Sell
27,270
-145
-0.5% -$14.5K 0.95% 51
2018
Q2
$2.34M Buy
27,415
+210
+0.8% +$17.2K 0.8% 58
2018
Q1
$2.1K Buy
27,205
+835
+3% +$67.2K 0.68% 61
2017
Q4
$2.23M Buy
26,370
+1,000
+4% +$85.1K 0.76% 61
2017
Q3
$2.17M Buy
25,370
+735
+3% +$60.3K 0.82% 63
2017
Q2
$2.03M Hold
24,635
0.77% 64
2017
Q1
$2.07M Sell
24,635
-25
-0.1% -$2K 0.83% 59
2016
Q4
$1.81M Sell
24,660
-895
-4% -$66.7K 0.77% 65
2016
Q3
$2.05M Buy
25,555
+14,450
+130% +$1.16M 0.93% 54
2016
Q2
$875K Sell
11,105
-100
-0.9% -$7.53K 0.39% 74
2016
Q1
$807K Sell
11,205
-645
-5% -$48.8K 0.37% 74
2015
Q4
$998K Sell
11,850
-640
-5% -$53.1K 0.46% 69
2015
Q3
$1.04M Sell
12,490
-70
-0.6% -$5.91K 0.55% 67
2015
Q2
$1.05M Sell
12,560
-280
-2% -$21.3K 0.66% 58
2015
Q1
$933K Hold
12,840
0.65% 59
2014
Q4
$886K Sell
12,840
-165
-1% -$11.1K 0.49% 64
2014
Q3
$843K Buy
13,005
+140
+1% +$8.86K 0.49% 61
2014
Q2
$800K Sell
12,865
-240
-2% -$14.3K 0.46% 65
2014
Q1
$771K Buy
13,105
+150
+1% +$8.37K 0.46% 69
2013
Q4
$661K Buy
12,955
+940
+8% +$47.1K 0.42% 65
2013
Q3
$605K Sell
12,015
-75
-0.6% -$3.93K 0.41% 69
2013
Q2
$594K Buy
+12,090
New +$658K 0.41% 68

Other funds holding LLY

Covington Investment Advisors's LLY Position: Q1 2026 in Review

Covington Investment Advisors reduced its Eli Lilly (LLY) stake by 3.7% in Q1 2026, selling an estimated $730K and leaving 18,653 shares worth $17.2M. The position accounts for 2.52% of the portfolio, ranked #9.

Covington Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Covington Investment Advisors held 18,653 shares of Eli Lilly worth $17.2M as of Q1 2026.
  • Covington Investment Advisors sold 720 Eli Lilly shares in Q1 2026, an estimated $730K.
  • Eli Lilly made up 2.52% of Covington Investment Advisors's portfolio in Q1 2026, its #9 holding.
  • Covington Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Covington Investment Advisors's Eli Lilly position peaked at $20.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Covington Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.